openPR Logo
Press release

Competitive Dynamics Of Antibody Technologies Market in Global Industry 2018

02-21-2018 11:19 AM CET | IT, New Media & Software

Press release from: Antibody Technologies Market

Competitive Dynamics Of Antibody Technologies Market in Global

Albany, NY, 21st February : Recent research and the current scenario as well as future market potential of "Antibody Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" globally.

Antibodies are referred as proteins produced by plasma cells of the body which are used by immune system to identify and fight against foreign bodies entering the host body.

Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1376082

Antibodies are also known as immunoglobulin (Ig). Antibodies are of Y shaped with specific binding site for specific antigen, a foreign body that provokes an adaptive immune response. Antibodies are secreted by type of white blood cells (WBCs) namely, plasma cells.

Immunity strength is observed to be directly proportional to age. With aging of population, the number of patients suffering diseases caused by weak immunity is increasing. Thus, factors such as global increase in the geriatric population, increasing research and development activity in the immunology field and availability of the government funds for research activities are driving the global antibody technologies market towards growth. On the other hand, lack of funds in developing economies, stringent regulatory framework and poor adoption of new technologies are some of the factors restraining the growth of the global antibody technologies market. Based on the type of antibody, the global antibody technologies market is segmented as follows:

Intravenous immunoglobulin (IVIg)
Microantibody
Single-domain antibody
Anti-mitochondrial antibodies
Secondary antibodies
Monoclonal antibody (mAb or moAb)
Anti-nuclear antibodies
Neutralizing antibody
Others

Make An Enquiry About TOC with tables & Figures @ https://www.researchmoz.us/enquiry.php?type=E&repid=1376082

Based on applications, the global antibody technologies market is segmented as follows:

Medical application
Disease diagnosis
Therapy
Prenatal therapy
Immunotherapy
Antibody therapy
Research applications
Proteins
Flow cytometry
Immunoprecipitation
Immunochemistry
Immunoprecipitation
Immunofluorescence
Others

On the grounds of increased research and development activities globally, immunofluorescence is the fastest growing segment among the available research applications. Disease diagnosis segment is leading the medical application segment due to advancements in research and thereby entry of improved techniques in the market. Monoclonal antibodies (mAb or moAb) is leading the segment and is followed by Intravenous immunoglobulin (IVIg) in the antibody type based antibody technology segment.

Geographically, the global antibody technologies market is categorized into North America, Europe, Asia-Pacific and rest of the world regions. North America currently leads global antibody technologies market and is followed by Europe. Factors that are fueling the growth of antibody technology market in the North America include existence of highly advanced technologies, early adoption of new technologies, developed healthcare infrastructure and supportive economy. Asia-Pacific is a lucrative market for antigen technologies and is predicted to undergo fast market growth. Particularly, countries such as India and China show growth potential, owing to factors such as government support to develop biotechnology industry in respective countries, rapidly improving healthcare infrastructure and increased healthcare spending. In addition, Asia Pacific countries mainly India and China will attract patients on the grounds of rapidly developing medical tourism industry in these countries and thereby resulting in increased demand for antibody technologies market in this region.

Browse Report @ https://www.researchmoz.us/antibody-technologies-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html

Some of the major players contributing to the global antibody technologies market include, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Biotest AG, Shanghai RAAS Blood Products Co. Ltd., China Biologic Products, Inc., Bharat Serums and Vaccines Ltd., OMRIX Biopharmaceuticals Ltd., Kedrion S.p.A, Beijing Tiantan Biological Products Co. Ltd., Huanlan Biological Engineering, Inc., Guizhou Taibang Biological Products Co. Ltd., Grifols S.A., CSL Behring LLC, Baxter International, Inc. and Octapharma AG.

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Competitive Dynamics Of Antibody Technologies Market in Global Industry 2018 here

News-ID: 951723 • Views:

More Releases for Antibodies

Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Arthritis Monoclonal Antibodies Market Report 2024 - Arthritis Monoclonal Antibo …
"The Business Research Company recently released a comprehensive report on the Global Arthritis Monoclonal Antibodies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The arthritis monoclonal antibodies
Global Multispecific Antibodies Market Size Antibodies Sales Forecast 2029
Global Multispecific Antibodies Market, Drug Sales, Price & Clinical Trials Insight 2029 Report Highlights: • Global & Regional Market Analysis • Global Multispecific Antibodies Market Opportunity: > USD 40 Billion • Global Multispecific Antibodies Market Sales In 2023: > USD 8 Billion • Number Of Approved Multispecific Antibodies: 14 • Approved Antibodies Global, Regional, Annual & Quarterly Sales Insight • Approved Antibodies Dosage & Pricing Insight • Number Of Multispecific Antibodies: In Clinical Trials: > 900 • Comprehensive Insight On All Antibodies In Clinical Trials By
Global Bispecific Antibody Market Size Bispecific Antibodies Clinical Trials FDA …
Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights: • Bispecific Antibodies Development Proprietary Platforms Insight: > 30 Platforms • Global Bispecific Antibodies Market Size Yearly and Quarterly Sales (2018 till 2023) • Global Bispecific Antibodies Market Size 2023: > USD 8 Billion • Global Bispecific Antibodies Market Forecast Till 2029 • Approved Bispecific Antibodies Yearly and Quarterly Sales (2018 till 2023) • Approved Bispecific Antibodies Regional Sales (2018 till 2023) • Clinical and Commercial Insight On Approved
Emergence of Tetravalent Antibodies
The emergence of tetravalent antibodies represents a significant advancement in the field of therapeutic antibodies, offering new possibilities for treating complex diseases such as cancer, infectious diseases, and autoimmune disorders. These innovative molecules, capable of binding to four antigens or epitopes simultaneously, provide enhanced specificity, efficacy, and versatility, addressing the limitations of traditional monoclonal and even bispecific antibodies. Download Bispecific, Trispecific and Tetraspecific Antibodies Report: https://www.kuickresearch.com/ccformF.php?t=1721642510 Tetravalent antibodies are designed to engage